Total Payments
$11,870
2024 Payments
$2,325
Companies
32
Transactions
328
Medicare Patients
42,655
Medicare Billing
$4.5M
Payment Breakdown by Category
Food & Beverage$10,033 (84.5%)
Other$1,838 (15.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,033 | 327 | 84.5% |
| Honoraria | $1,838 | 1 | 15.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $2,660 | 23 | $0 (2023) |
| Allergan, Inc. | $1,003 | 34 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $1,002 | 35 | $0 (2024) |
| ABBVIE INC. | $941.28 | 27 | $0 (2024) |
| Glaukos Corporation | $773.81 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $727.10 | 38 | $0 (2023) |
| Alcon Vision LLC | $571.37 | 22 | $0 (2024) |
| Amgen Inc. | $555.04 | 24 | $0 (2024) |
| Shire North American Group Inc | $376.11 | 17 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $375.21 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,325 | 88 | Amgen Inc. ($555.04) |
| 2023 | $4,680 | 83 | Horizon Therapeutics plc ($2,506) |
| 2022 | $1,246 | 41 | ABBVIE INC. ($257.89) |
| 2021 | $688.77 | 27 | Allergan, Inc. ($173.92) |
| 2020 | $445.24 | 14 | Eyevance Pharmaceuticals LLC ($162.45) |
| 2019 | $714.63 | 16 | Glaukos Corporation ($334.98) |
| 2018 | $1,069 | 31 | Allergan Inc. ($305.01) |
| 2017 | $701.44 | 28 | Allergan Inc. ($287.00) |
All Payment Transactions
328 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Ophthalmology | ||||||
| 12/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/18/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Ophthalmology | ||||||
| 12/14/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $32.26 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/05/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: OPTOMETRY | ||||||
| 12/03/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/22/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/18/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/15/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $103.10 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: OPTOMETRY | ||||||
| 11/07/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/26/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $32.96 | General |
| Category: Ophthalmology | ||||||
| 10/25/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $35.55 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/19/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $200.22 | General |
| Category: Glaucoma | ||||||
| 10/18/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Ophthalmology | ||||||
| 10/17/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: OPTOMETRY | ||||||
| 10/10/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/08/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/01/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Ophthalmology | ||||||
| 09/25/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: OPTOMETRY | ||||||
| 09/19/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 11,011 | 17,249 | $2.7M | $1.3M |
| 2022 | 35 | 10,895 | 17,124 | $2.5M | $1.1M |
| 2021 | 39 | 10,818 | 21,290 | $2.5M | $1.2M |
| 2020 | 36 | 9,931 | 18,057 | $2.0M | $925,773 |
Total Patients
42,655
Total Services
73,720
Medicare Billing
$4.5M
Procedure Codes
142
All Medicare Procedures & Services
142 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,027 | 2,219 | $266,370 | $182,189 | 68.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 21 | 218 | $215,820 | $150,417 | 69.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 985 | 1,309 | $261,410 | $149,514 | 57.2% |
| 92134 | Imaging of retina | Office | 2023 | 1,138 | 2,916 | $291,600 | $103,023 | 35.3% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 1,004 | 1,022 | $255,500 | $89,319 | 35.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 113 | 752 | $225,600 | $78,745 | 34.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 809 | 874 | $113,620 | $50,955 | 44.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 292 | 292 | $64,240 | $44,228 | 68.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 283 | 363 | $58,080 | $43,107 | 74.2% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 141 | 407 | $113,960 | $42,186 | 37.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 55 | 69 | $61,410 | $35,336 | 57.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 110 | 613 | $73,560 | $34,240 | 46.5% |
| 92025 | Ct scan of cornea | Office | 2023 | 1,001 | 1,055 | $84,400 | $33,418 | 39.6% |
| 92250 | Photography of the retina | Office | 2023 | 972 | 1,018 | $203,600 | $32,539 | 16.0% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 41 | 45 | $58,500 | $31,186 | 53.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 945 | 965 | $48,250 | $24,540 | 50.9% |
| 92285 | Photography of content of eyes | Office | 2023 | 930 | 996 | $64,740 | $20,809 | 32.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 136 | 150 | $45,000 | $19,478 | 43.3% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 50 | 60 | $28,800 | $18,927 | 65.7% |
| 66761 | Creation of eye fluid drainage tracts in iris using a laser, per session | Office | 2023 | 28 | 44 | $19,800 | $12,421 | 62.7% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 37 | 46 | $25,300 | $11,775 | 46.5% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 42 | 52 | $31,200 | $11,221 | 36.0% |
| 68840 | Probing of nasal tear duct | Office | 2023 | 39 | 50 | $12,500 | $9,021 | 72.2% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 213 | 213 | $35,784 | $8,938 | 25.0% |
| 76511 | 1d ultrasound scan of eye tissue and structures | Office | 2023 | 70 | 75 | $13,500 | $6,308 | 46.7% |
About Dr. Stanley Bykov, MD
Dr. Stanley Bykov, MD is a Ophthalmology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972539112.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stanley Bykov, MD has received a total of $11,870 in payments from pharmaceutical and medical device companies, with $2,325 received in 2024. These payments were reported across 328 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($10,033).
As a Medicare-enrolled provider, Bykov has provided services to 42,655 Medicare beneficiaries, totaling 73,720 services with total Medicare billing of $4.5M. Data is available for 4 years (2020–2023), covering 142 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Brooklyn, NY
- Active Since 06/22/2006
- Last Updated 07/21/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972539112
Products in Payments
- TEPEZZA (Drug) $2,660
- XIIDRA (Drug) $1,014
- VUITY (Drug) $656.73
- TEPEZZA (Biological) $555.04
- LUMIGAN (Drug) $543.68
- VYZULTA (Drug) $394.86
- MIEBO (Drug) $344.96
- iStent inject Trabecular Micro-Bypass Stent System (Device) $334.98
- RESTASIS (Drug) $286.12
- Simbrinza (Drug) $259.49
- EYLEA HD (Biological) $250.85
- Flarex (Drug) $244.59
- Rhopressa (Drug) $242.81
- iDose (Device) $200.22
- enVista MX60 IOL (Device) $198.98
- VEVYE (Drug) $170.30
- PROKERA (Device) $169.91
- XDEMVY (Drug) $165.47
- TYRVAYA (Drug) $158.97
- Syfovre (Drug) $155.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Brooklyn
David Rubaltelli, M.d, M.D
Ophthalmology — Payments: $8.9M
Ophthalmology $8.9M
Dr. Irene Gladstein, M.d, M.D
Ophthalmology — Payments: $106,815
Ophthalmology $106,815
Mr. Raphael Rosenbaum, M.d, M.D
Ophthalmology — Payments: $40,149
Ophthalmology $40,149
Dr. Leonard Bley, M.d, M.D
Ophthalmology — Payments: $23,405
Ophthalmology $23,405
Dr. Bradley Phillips, M.d, M.D
Ophthalmology — Payments: $16,804
Ophthalmology $16,804
Joseph Zelefsky, Md, MD
Ophthalmology — Payments: $12,170
Ophthalmology $12,170